4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-047107
EVP, R&D & Chief Scientific Of sold 775 shares at $37.54 ($29,094)
From the SEC's structured data for this filing
Trades in this filing
Haqq Christopher · EVP, R&D & Chief Scientific Of
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-08-15 | Sale : show line 1 in the form | −775 | $37.54 | $29,094 | 331,355 | D |
| Open-market sales · 775 sh · avg $37.54 · $29,094 | ||||||
Loading xslF345X03/doc4.xml…